Article Data

  • Views 3223
  • Dowloads 299

Original Research

Open Access

Quality of life and psychological assessment in patients with Fibromyalgia Syndrome during COVID-19 pandemic in Italy: prospective observational study

  • Vittorio Schweiger1
  • Erica Secchettin1
  • Giovanni Perini1
  • Alvise Martini1
  • Katia Donadello1
  • Leonardo Gottin1
  • Giovanna Del Balzo2
  • Giustino Varrassi3
  • Enrico Polati1

1Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, 37134 Verona, Italy

2Department of Medicine and Public Health, University of Verona, 37134 Verona, Italy

3Fondazione Paolo Procacci and European League against Pain, 00185 Rome, Italy

DOI: 10.22514/sv.2021.127 Vol.18,Issue 1,January 2022 pp.41-46

Submitted: 22 April 2021 Accepted: 30 June 2021

Published: 08 January 2022

*Corresponding Author(s): Erica Secchettin E-mail:


Introduction: Chronic pain patients who undergo to stressful events may experience worsening in pain, sleep, and quality of life (QoL). The primary objective of this observational study was to compare QoL and sleep parameters before and after the COVID-19 lockdown in patients with Fibromyalgia Syndrome (FMS). The psychological impact of lockdown was also assessed, as well as the emotional impact of the pandemic and its correlations with patient socio-demographics.

Methods: Patients aged ≥18 years with FMS diagnosed according to ACR (American College of Rheumatology) 2016 Criteria with at least one pre-pandemic QoL and sleep evaluation were included. QoL and sleep disturbances were analyzed by comparing scores on the Fibromyalgia Impact Questionnaire-Revised (FIQ-R), the 12-item Short Form Survey (SF-12), and the Pittsburgh Sleep Quality Index (PSQI) before and after the first lockdown in Italy (March to May 2020). Psychological impact was investigated via a 52-item survey of daily life changes in FMS management during the lockdown and emotional impact with the Impact Event Scale-Revised (IES-R) tool during the onset period after the lockdown. Questionnaire responses were correlated with patients’ socio-demographics.

Results: Questionnaires were submitted via email to 54 patients; 37/54 patients (63.7%) returned them. QoL and sleep disturbances showed no statistically significant worsening. However, the psychological impact survey revealed that 3 out of 5 patients feared very much for their family members’ lives during lockdown. The emotional impact survey disclosed 72.7% of patients with psychological distress.

Conclusions: While questionnaire responses showed no significant changes in QoL and sleep after the COVID-19 lockdown in this sample of FMS patients, the emotional investigation revealed moderate/severe psychological distress not detected by commonly used QoL tests in FMS.


Fibromyalgia; Quality of life; Depression; Sleep; COVID-19 pandemic

Cite and Share

Vittorio Schweiger,Erica Secchettin,Giovanni Perini,Alvise Martini,Katia Donadello,Leonardo Gottin,Giovanna Del Balzo,Giustino Varrassi,Enrico Polati. Quality of life and psychological assessment in patients with Fibromyalgia Syndrome during COVID-19 pandemic in Italy: prospective observational study. Signa Vitae. 2022. 18(1);41-46.


[1] Clauw DJ, Arnold LM, McCarberg BH. The Science of Fibromyalgia. Mayo Clinic Proceedings. 2011; 86: 907–911.

[2] Schweiger V, Del Balzo G, Raniero D, De Leo D, Martini A, Sarzi-Puttini P, et al. Current trends in disability claims due to fibromyalgia syndrome. Clinical and Experimental Rheumatology. 2017; 35: 119–126.

[3] Coaccioli S, Varrassi G, Sabatini C, Marinangeli F, Giuliani M, Puxeddu A. Fibromyalgia: nosography and therapeutic perspectives. Pain Practice. 2008; 8: 190–201.

[4] Rahman A, Underwood M, Carnes D. Fibromyalgia. British Medical Journal. 2014; 348: g1224.

[5] Yasui M, Yoshimura T, Takeuchi S, Tokizane K, Tsuda M, Inoue K, et al. A chronic fatigue syndrome model demonstrates mechanical allodynia and muscular hyperalgesia via spinal microglial activation. Glia. 2015; 62: 1407–1417.

[6] Salaffi F, Atzeni F, Talotta R, Di Carlo M, Sarzi-Puttini P. Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy. Clinical and Experimental Rheumatology. 2017; 35: 93–99.

[7] Usui C, Hatta K, Aratani S, Yagishita N, Nishioka K, Okamura S, et al. Vulnerability to traumatic stress in fibromyalgia patients: 19 month follow-up after the great East Japan disaster. Arthritis Research & Therapy. 2013; 15: R130.

[8] Allen SF, Stevenson J, Lazuras L, Akram U. The role of the COVID-19 pandemic in altered psychological well-being, mental health and sleep: an online cross-sectional study. Psychology, Health & Medicine. 2021; 1–9.

[9] Souza LFF, Paineiras-Domingos LL, Melo-Oliveira MES, Pessanha-Freitas J, Moreira-Marconi E, Lacerda ACR, Mendonça VA, Sá-Caputo DDC, Bernardo-Filho M. The impact of COVID-19 pandemic in the quality of sleep by Pittsburgh Sleep Quality Index: a systematic review. Ciência & Saúde Coletiva. 2021; 26: 1457–1466.

[10] Soares LL, Leite LB, Guilherme LQ, Rezende LM, Noce F, Pussieldi G. Anxiety, sleep quality and mood in elite athletes during the COVID-19 pandemic: a preliminary study. The Journal of Sports Medicine and Physical Fitness. 2021. (in press)

[11] Sonza A, Da Cunha de Sá-Caputo D, Bachur JA, Rodrigues de Araújo MDG, Valadares Trippo KVT, Ribeiro Nogueira da Gama DRNDG, et al. Brazil before and during COVID-19 pandemic: impact on the practice and habits of physical exercise. Acta BioMedica. 2020; 92: e2021027.

[12] Melo-Oliveira ME, Sá-Caputo D, Bachur JA, Paineiras-Domingos LL, Sonza A, Lacerda AC, et al. Reported quality of life in countries with cases of COVID19: a systematic review. Expert Review of Respiratory Medicine. 2021; 15: 213–220.

[13] Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Research & Therapy. 2009; 11: R120.

[14] Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. International Journal of Clinical Practice. 2008; 62: 115–126.

[15] Osorio CD, Gallinaro AL, Lorenzi-Filho G, Lage LV. Sleep quality in patients with fibromyalgia using the Pittsburgh Sleep Quality Index. Journal of Rheumatology. 2006; 33: 1863–1865.

[16] Craparo G, Faraci P, Rotondo G, Gori A. The Impact of Event Scale -Revised: psychometric properties of the Italian version in a sample of flood victims. Neuropsychiatric Disease and Treatment. 2013; 9: 1427–1432.

[17] Martini A, Schweiger V, Del Balzo G, Sartori G, Parolini M, Chinellato E, et al. Epidemiological, pharmacological and sociodemographic characterization of a population of 386 fibromyalgic patients referred to a tertiary pain centre in Italy. Clinical and Experimental Rheumatology. 2019; 37: 27–38.

[18] Osimo SA, Aiello M, Gentili C, Ionta S, Cecchetto C. The influence of personality, resilience, and alexithymia on mental health during COVID-19 Pandemic. Frontiers in Psychology. 2021; 4: 630751.

[19] Cecchetto C, Aiello M, Gentili C, Ionta S, Osimo SA. Increased emotional eating during COVID-19 associated with lockdown, psychological and social distress. Appetite. 2021; 160: 105122.

[20] Conversano C, Marchi L, Rebecca C, Carmassi C, Contena B, Bazzichi LM, et al. Personality Traits in Fibromyalgia (FM): does FM personality exists? a Systematic Review. Clinical Practice and Epidemiology in Mental Health. 2018; 14: 223–232.

[21] Cavalli G, Cariddi A, Ferrari J, Suzzi B, Tomelleri A, Campochiaro C, et al. Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients. Rheumatology. 2021; 60: 465–467.

[22] Jeppesen SS, Bentsen KK, Jørgensen TL, Holm HS, Holst-Christensen L, Tarpgaard LS, et al. Quality of life in patients with cancer during the COVID-19 pandemic – a Danish cross-sectional study (COPICADS). Acta Oncologica. 2021; 60: 4–12.

[23] Ciążynska M, Pabianek M, Szczepaniak K, Ułanska M, Skibinska M, Owczarek W, et al. Quality of life of cancer patients during coronavirus disease (COVID-19) pandemic. Psycho-Oncology. 2020; 1–3.

[24] Deledda G, Riccardi N, Gori S, Poli S, Giansante M, Geccherle E, et al. The impact of the SARS-CoV-2 outbreak on the psychological flexibility and behavior of cancelling medical appointments of italian patients with pre-existing medical condition: The “ImpACT-COVID-19 for patients” multi-centre observational study. International Journal of Environmental Research and Public Health. 2021; 18: 340.

[25] Passavanti M, Argentieri A, Barbieri DM, Lou B, Wijayaratna K, Foroutan Mirhosseini AS, et al. The psychological impact of COVID-19 and restrictive measures in the world. Journal of Affective Disorders. 2021; 283: 36–51.

[26] Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: Classification and criteria changes. World Psychiatry. 2013; 12: 92–98.

[27] O’Donnell ML, Agathos JA, Metcalf O, Gibson K, Lau W. Adjustment Disorder: Current Developments and Future Directions. International Journal of Environmental Research and Public Health. 2019; 16: 2537.

[28] Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, et al. Patient perspectives on the impact of fibromyalgia. Patient Education and Counseling. 2008; 73: 114–120.

[29] Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N. Self-reported functioning and well-being in patients with Parkinson’s disease: comparison of the short-form health survey (SF-36) and the Parkinson’s Disease Questionnaire (PDQ-39) Age and Ageing. 1995; 24: 505–509.

[30] Spaeth M, Rizzi M, Sarzi-Puttini P. Fibromyalgia and sleep. Best Practice & Research. Clinical Rheumatology. 2011; 25: 227–239.

[31] Hruschak V, Flowers KM, Azizoddin DR, Jamison RN, Edwards RR, Schreiber KL. Cross-sectional study of psychosocial and pain-related variables among patients with chronic pain during a time of social distancing imposed by the coronavirus disease 2019 pandemic. Pain. 2021; 162: 619–629.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time